Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ritalin on cardiac autonomic function in children after acquired brain injury
MOH_2025-10-06_014373Phase 2Not yet recruiting
- Sponsor
- גלעד שורק
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by גלעד שורק. Primary endpoint: Heart rate variability at rest and paced breathing. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on MOH_2025-10-06_014373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-10-06_014373.